Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More
NCT06954818
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Zoster
Interventions
BIOLOGICAL:
A zoster mRNA vaccine SYS6017
OTHER:
Placebo
Sponsor
CSPC Megalith Biopharmaceutical Co.,Ltd.